1. Home
  2. ERIC vs TEVA Comparison

ERIC vs TEVA Comparison

Compare ERIC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ericsson

ERIC

Ericsson

HOLD

Current Price

$11.25

Market Cap

37.2B

Sector

Technology

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$33.38

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERIC
TEVA
Founded
1876
1901
Country
Sweden
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.2B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ERIC
TEVA
Price
$11.25
$33.38
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$10.40
$37.25
AVG Volume (30 Days)
9.9M
9.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.46
$2.97
P/E Ratio
$12.13
$28.19
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$12.47
52 Week High
$11.38
$37.35

Technical Indicators

Market Signals
Indicator
ERIC
TEVA
Relative Strength Index (RSI) 69.02 50.68
Support Level $11.08 $33.70
Resistance Level $11.38 $35.32
Average True Range (ATR) 0.19 1.04
MACD -0.01 -0.22
Stochastic Oscillator 100.00 4.45

Price Performance

Historical Comparison
ERIC
TEVA

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: